Bactericidal activity of normal bovine serum (NBS) directed against some Enterobacteriaceae with sialic acid-containing lipopolysaccharides (LPS) as a component of cell wall

Polish Journal of Microbiology

Volumn 55, Issue 3, 2006, Pages 169-174

  Bugla Płoskońska, Gabriela ^a   Doroszkiewicz, Włodzimierz ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

Gram negative bacteria; Lipopolysaccharide; Normal bovine serum (NBS); Sialic acid

Indexed keywords

BOVINE SERUM ALBUMIN; LIPOPOLYSACCHARIDE; NORMAL BOVINE SERUM; SIALIC ACID;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CITROBACTER BRAAKII; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; NONHUMAN; SALMONELLA ENTERICA; SEROTYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD BACTERICIDAL ACTIVITY; CATTLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROBACTERIACEAE; LIPOPOLYSACCHARIDES; N-ACETYLNEURAMINIC ACID; SERUM;

ANIMALIA; BACILLI (CLASS); BACTERIA (MICROORGANISMS); BOS TAURUS; CITROBACTER BRAAKII; ENTEROBACTERIACEAE; ESCHERICHIA COLI; NEGIBACTERIA; SALMONELLA ENTERICA;

EID: 33845608057     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bugla G., W. Doroszkiewicz, A. Gamian and A. Korzeniowska-Kowal. 2004. Bactericidal activity of normal human serum against Gram-negative bacilli with lipopolysaccharide-sialic acid (in Polish). Med. Dośw. Microbiol. 51: 255-261.
2. Cisowska A. and S. Jankowski. 2004. The sensitivity of Escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum. Folia Microbiol. 49: 471-478.
3. Delabac Y. 1968. The sensitivity of smooth and rough mutants of Salmonella typhimurium to bactericidal and bacteriolytic action of serum, lysozyme and phagocytosis. Folia Microbiol. 13: 439-442.
4. Devine D.A. and A.P. Roberts. 1994. K1, K5 and O-antigen Escherichia coli in relation to serum killing via the classical and alternative complement pathways. J. Med. Microbiol. 41: 139-144.
5. + recombinant to killing action of serum. Arch. Immunol. Ther. Exp. 45: 235-242.
6. Doroszkiewicz W., R. Pokładek and T.M. Lachowicz. 1994. Mechanism of antigenic variation in Shigella flexneri. II. Sensitivity to complement as a selection factor for antigenic mutant 3b in 1b serotype. Arch. Immunol. Ther. Exp. 42: 155-158.
7. Edinger D., E. Bello and A. Mates. 1977. The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells. Cell Immunol. 29: 174-186.
8. Egan W., T.-Y. Liu, D. Dorrow, J.S. Cohen, J.D. Robbins, E.C. Gotschlich and J.B. Robbins. 1977. Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12. Biochemistry 16: 3687-3692.
9. Fine D.P., S.R. Marney, D.G. Colley, J.S. Sergent and R.M. Des Perez. 1972. C3 shunt activation in human serum chelated with EGTA. J. Immunol. 109: 807-809.
10. Gamian A. 1996. Studies on enterobacterial lipopolysaccharides containing sialic acid (in Polish). Post. Microbiol. 4: 491-493.
11. 1H NMR spectroscopy. Biochemistry 30: 5032-5038.
12. Gamian A., E. Romanowska, J. Orlich and J. Defaye. 1992. The structure of sialic acid-containing O-specific polysaccharide and its linkage to the core region in lipopolysaccharide from Escherichia coli O104. Carbohydr. Res. 236: 195-196.
13. nd Conference International Endotoxin Society, Vienna, 1992. Abstr. 72.
14. Gamian A., A. Romanowska and E. Romanowska. 1992b. Immunochemical studies on sialic acid-containing lipopolysaccharides from enterobacterial species. FEMS Microbiol. Immunol. 89: 323-328.
15. Gamian A. and L. Kenne. 1993. Analysis of 7-substituted sialic acid in some enterobacterial lipopolysaccharides. J. Bacteriol. 175: 1508-1513.
16. Gamian A., L. Kenne, M. Mieszała, J. Urlich and J. Defaye. 1994. Structure of the Escherichia coli O24 and O56 O-specific sialic-acid-containing polysaccharides and linkage of these structures to the core region in lipopolysaccharides. Eur. J. Biochem. 225: 1211-1212.
17. Gamian A., T. Lipinski, A. Korzeniowska-Kowal and N. Ravenscroft. 2000. Structure of the sialic acid-containing O-specific polysaccharide from Salmonella enterica serovar Toucra O48 lipopolysaccharide. Eur. J. Biochem. 267: 3160-3166.
18. Jankowski S. 1994. The role of complement and antibodies in the impaired bactericidal activity of neonatal sera against Gram-negative bacteria. Acta Microbiol. Pol. 44: 5-14.
19. Jankowski S., S. Rowiński, A. Cisowska and A. Gamian. 1996. The sensitivity of Hafnia alvei strains to bactericidal effect of serum. FEMS Immun. Med. Microb. 13: 59-64.
20. Jann K. and B. Jann. 1977. Bacterial polysaccharides antigens. Surface carbohydrates of the prokaryotic cell. Ed: Southerland I.W., Academic Press, London, pp. 247-297.
21. Kȩdzierska B. 1978. N-acetylneuraminic acid: a constituent of the lipopolysaccharide of Salmonella toucra. Eur. J. Bochem. 91: 545-552.
22. Lachowicz M.T., W. Doroszkiewicz and J. Niedbach. 1999. Environment implication of lipopolysaccharide dependent normal serum sensitivity of Shigella flexnerii serotypes. Nova Acta Leopoldina 312: 235-243.
23. Marques M.B., D.L. Kasper, M.K. Pangburn and M.R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60: 3986-3993.
24. Matsushita M., Y. Mendo and T. Fuijta. 1998. MASP-1 (MBL-associated serine protease 1). Immunobiol. 199: 340-347.
25. Meri S. and M.K. Pangburn. 1990. Discrimination between activators and nonactivators of the alternative pathway of complement regulation via a sialic acid/polyanion-binding ste on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3993.
26. Mielnik G., A. Gamian and W. Doroszkiewicz. 2001. Bactericidal activity of normal cord serum (NCS) against Gram-negative rods with sialic acid-containing lipopolysaccharides (LPS). FEMS Immnol. Med. Microbiol. 31: 169-173.
27. Mokracka-Latajka G., S. Jankowski, K. Grzybek-Hryncewicz and B. Krżyzanowska. 1996. The mechanism of bactericidal action of normal human serum against Salmonella rods. Acta Microbiol. Pol. 45: 169-180.
28. Moran A.P., M.M. Prendergast and B.J. Appelmelk. 1996. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Med. Microbiol. 16: 105-115.
29. :z35:- isolated in southern Italy. Ann. Inst. Pasteur Microbiol. 139: 605-612.
30. Orskov I., F. Orskov, B. Jann and K. Jann. 1977. Serology, chemistry and genetics of O and K antigens of Escherichia coli. Bacteriol. Rev. 41: 667-710.
31. Ram S., F.G. Mackinnon, S. Gulati, D.P. McQuillen, U. Vogel, M. Frosch, C. Elkins, H.K. Guttormsen, L.M. Wetzer, M. Oppermann, M.K. Pangburn and P.A. Rice. 1999. The contrasting mechanisms of serum resistance of Neisseria gonorrhoae and group B Neisseria meningitidis. Molec. Immunol. 36: 915-928.
32. Rautemaa R. and S. Meri. 1999. Complement-resistance mechanisms of bacteria. Microb. Infect. 1: 785-794.
33. Romanowska A., E. Katzenellenbogen, M. Kulakowska, A. Gamian, D. Witkowska, M. Kulczyk and E. Romanowska. 1988. Hafnia alvei lipopolysaccharides: isolation, sugar composition and SDS-PAGE analysis. FEMS Microbiol. Immunol. 47: 151-156.
34. Taylor P.W. 1995. Resistance of bacteria to complement. Virulence mechanism of bacterial pathogen. Roth, J.A., (Ed.) Am. Soc. Microbiol., Washington, D.C.
35. Vimir E.R., K.A. Kalivoda, E.L. Deszo and S.M. Steenbergen. 2004. Diversity of microbial sialic acid metabolism. Microbiol. Molec. Biol. Rev. 68: 132-153.